1 |
Rahman MA, Dhar DK, Yamaguchi E, et al. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res, 2001, 7(5): 1325-1332.
|
2 |
Xue LY, Hu N, Song YM, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer, 2006, 6: 296.
|
3 |
曹良启, 汪谦, 陈锡林, 等. 15-脱氧前列腺素J2体外诱导肝癌细胞失巢凋亡的研究. 中华医学杂志, 2007, 87(42): 3001-3005.
|
4 |
Toyoda M, Takagi H, Horiguchi N, et al. A ligand for peroxisome proliferators activated receptor γ inhibitor cell growth and induces apoptosis in human liver cancer cells. Gut, 2002, 50(4): 563-567.
|
5 |
Yu J, Qiao L, Zimmermann L, et al. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology, 2006, 43(1): 134-143.
|
6 |
Terashita Y, Sasaki H, Haruki N, et al. Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol, 2002, 32(7): 238-243.
|
7 |
Tamguney T, Stokoe D. New insights into PTEN. J Cell Sci, 2007, 120(Pt23): 4071-4079.
|
8 |
Fujiwara Y, Hoon DS, Yamada T, et al. PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res, 2000, 91(3): 287-292.
|
9 |
Lu D, Zhang X, Cao X. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer. J Cell Nol Med, 2003, 7(1): 67-71.
|
10 |
Rahman MA, Kyriazanos ID, Ono T, et al. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase. Int J Cancer, 2002, 100(2): 152-157.
|
11 |
Tanno S, Tanno S, Mitsuuchi Y, et al. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res, 2001, 61(2): 589-593.
|
12 |
曹良启, 陈锡林, 汪谦. 核蛋白受体对肝癌相关基因表达的信号转导调控[J/CD]. 中华普通外科学文献:电子版, 2007, 1(3): 136-138.
|
13 |
Patel L, Pass I, Coxon P, et al. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol, 2001, 11(10): 764-768.
|
14 |
Cao LQ, Chen XL, Wang Q, et al. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells. Acta Pharmacol Sin, 2007, 28(6): 879-887.
|